Expertise in
35
conditions

Dr. John C. Barrett

Hematology
Office
1001 E Leigh St Fl 4, 
Richmond, VA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
35
conditions
Office
1001 E Leigh St Fl 4, 
Richmond, VA 

Overview

John Barrett is a Hematologist practicing medicine in Richmond, Virginia.

Dr. Barrett is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilia B, Hemophilic Arthropathy, Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 3 clinical trials. Dr. Barrett is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in VA

Hospital Affiliations

Medical College Of Virginia Hospitals
Vcu Health Tappahannock Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
1001 E Leigh St Fl 4, Richmond, VA 23298

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Biological, Drug, Procedure, Other
Study Drugs: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab
Study Phase: Phase 3
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Drug, Procedure, Biological
Study Drugs: Blinatumomab, Cyclophosphamide, Cytarabine, Daunorubicin, Daunorubicin Hydrochloride, Dexamethasone, Etoposide, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone, Rituximab, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)
ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)
Enrollment Status: Completed
Publish Date: July 13, 2026
View 2 Less Clinical Trial

10 Total Publications

Trends of women in cardiovascular disease fellowships 2013-2022.
Trends of women in cardiovascular disease fellowships 2013-2022.
Journal: American heart journal
Published: October 21, 2024
Similar Doctors
Expertise in
30
conditions
Dr. Sosipatros A. Boikos
Hematology | Oncology
Expertise in
30
conditions
Dr. Sosipatros A. Boikos
Hematology | Oncology
Referral may be required

Virginia Commonwealth University Health System Authority

1250 E Marshall St, 
Richmond, VA 
 (1.9 miles away)
804-828-7999
Languages Spoken:
English, Greek
See accepted insurances
Accepting New Patients

Sosipatros Boikos is a Hematologist and an Oncologist practicing medicine in Richmond, Virginia. Dr. Boikos is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Neuroendocrine Tumor, and Bone Marrow Aspiration. Dr. Boikos is currently accepting new patients.

Expertise in
59
conditions
Dr. James L. Khatcheressian
Hematology | Hematology Oncology
Expertise in
59
conditions
Dr. James L. Khatcheressian
Hematology | Hematology Oncology
Referral may be required

Virginia Cancer Institute - West End

8007 Discovery Drive, Suite A, 
Richmond, VA 
 (5.9 miles away)
804-287-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Khatcheressian is a Hematologist and a Hematologist Oncology provider practicing medicine in Richmond, Virginia. Dr. Khatcheressian is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Khatcheressian is board certified in (Internal Medicine, Medical Oncology) and American Board Of Internal Medicine. Dr. Khatcheressian is currently accepting new patients.

Expertise in
18
conditions
Dr. Beata H. Holkova
Hematology | Oncology
Expertise in
18
conditions
Dr. Beata H. Holkova
Hematology | Oncology
Referral may be required

Virginia Commonwealth University Health System Authority

1300 E Marshall St, 
Richmond, VA 
 (2.0 miles away)
804-828-7999
Languages Spoken:
English
See accepted insurances

Beata Holkova is a Hematologist and an Oncologist practicing medicine in Richmond, Virginia. Dr. Holkova is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), Hereditary Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. John C. Barrett

How do I make an appointment with Dr. John C. Barrett?

You can book an appointment with Dr. John C. Barrett by calling their office at 804-828-7929. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John C. Barrett a top-rated expert for Hemophilia A?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John C. Barrett is classified as an Distinguished expert for Hemophilia A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John C. Barrett specialize in?

While Dr. John C. Barrett is a Hematology, they have specific expertise in Hemophilia A, Hemophilia B, and Hemophilic Arthropathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. John C. Barrett participate in research or clinical trials?

Yes. Dr. John C. Barrett has published 10 articles and abstracts on conditions like Hemophilia A. You can view a list of Dr. John C. Barrett's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John C. Barrett accept my insurance?

Dr. John C. Barrett accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 804-828-7929 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Barrett's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 26 Advanced Conditions
    View All 53 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile